{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T07:11:36Z","timestamp":1698822696374},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T00:00:00Z","timestamp":1321488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Reversal of renal impairment (RI) in patients with multiple myeloma (MM) has been evaluated using the estimated glomerular filtration rate (eGFR<jats:sub>MDRD<\/jats:sub>) formula developed by the Modification of Diet in Renal Disease study group. However, the prognostic impact of eGFR<jats:sub>MDRD<\/jats:sub> at diagnosis of MM is not well studied, particularly its use in conjunction with the International Staging System (ISS).<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Newly diagnosed patients with MM were enrolled between 1996 and 2007. Data on clinical features, laboratory tests, and overall survival were compared in terms of corresponding eGFR<jats:sub>MDRD<\/jats:sub>.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> A total of 387 patients with MM (median age, 71\u2003yr) were enrolled. At diagnosis, 56% had ISS stage III disease; the median values of serum creatinine (SCr) and eGFR<jats:sub>MDRD<\/jats:sub> were 1.4\u2003mg\/dL and 38.2\u2003mL\/min\/1.73\u2003m<jats:sup>2<\/jats:sup>, respectively. Thirty\u2010four percent of patients had SCr of \u22652.0\u2003mg\/dL, and 81.2% had chronic kidney disease stages 3\u20135 (CKD 3\u20135). Higher CKD stages were significantly more common in men, older patients (\u226565\u2003yr), and those with Durie\u2013Salmon and ISS stage III, light\u2010chain diseases, anemia, thrombocytopenia, hypercalcemia, elevated serum \u03b2<jats:sub>2<\/jats:sub> microglobulin, or lactate dehydrogenase. In the Cox regression model, CKD 4\u20135 or CKD 5 alone was independently associated with poor survival. A diagnosis of CKD 5 was shown to be useful in identifying the subgroup of ISS\u2010III patients at high risk \u2013 those with a median overall survival of 7.2\u2003months.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Our study demonstrates the prognostic impact of eGFR<jats:sub>MDRD<\/jats:sub> in patients with MM and CKD 5 as the ISS\u2010independent surrogate predictor of poorest prognosis.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2011.01717.x","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T14:03:17Z","timestamp":1317736997000},"page":"159-166","source":"Crossref","is-referenced-by-count":8,"title":["Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma"],"prefix":"10.1111","volume":"88","author":[{"given":"Liang\u2010Tsai","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching\u2010Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng\u2010Hsiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyh\u2010Pyng","family":"Gau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan\u2010Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying\u2010Chung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun\u2010Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin\u2010Hwang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po\u2010Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzeon\u2010Jye","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng\u2010Hwai","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.242"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr276"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00040031693017"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.17.1889"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2086"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.3038"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp488"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.8791"},{"key":"e_1_2_6_11_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_6_12_2","article-title":"International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents","author":"Yang SH","year":"2011","journal-title":"Ann Hematol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.402"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0841-4"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb00190.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.4065\/78.1.21"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01318.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90221.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1928"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.036947"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.000638"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2006.21.4.639"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10759"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04590908"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-258608"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0813-8"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21922"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770100330"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.2114"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60952-6"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2010.01304.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.077"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.543125"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2011.01717.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2011.01717.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:12:11Z","timestamp":1698757931000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2011.01717.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1600-0609.2011.01717.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01717.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,17]]}}}